IBDEI2UG ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45365,1,3,0)
;;=3^Myocardial infarctions (STEMI), unspec site
;;^UTILITY(U,$J,358.3,45365,1,4,0)
;;=4^I21.3
;;^UTILITY(U,$J,358.3,45365,2)
;;=^5007087
;;^UTILITY(U,$J,358.3,45366,0)
;;=I25.10^^172^2266^2
;;^UTILITY(U,$J,358.3,45366,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45366,1,3,0)
;;=3^Athscl hrt disease w/o angina pectoris
;;^UTILITY(U,$J,358.3,45366,1,4,0)
;;=4^I25.10
;;^UTILITY(U,$J,358.3,45366,2)
;;=^5007107
;;^UTILITY(U,$J,358.3,45367,0)
;;=I25.2^^172^2266^20
;;^UTILITY(U,$J,358.3,45367,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45367,1,3,0)
;;=3^Old myocardial infarction
;;^UTILITY(U,$J,358.3,45367,1,4,0)
;;=4^I25.2
;;^UTILITY(U,$J,358.3,45367,2)
;;=^259884
;;^UTILITY(U,$J,358.3,45368,0)
;;=I30.0^^172^2266^14
;;^UTILITY(U,$J,358.3,45368,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45368,1,3,0)
;;=3^Idiopathic pericarditis, acute
;;^UTILITY(U,$J,358.3,45368,1,4,0)
;;=4^I30.0
;;^UTILITY(U,$J,358.3,45368,2)
;;=^5007157
;;^UTILITY(U,$J,358.3,45369,0)
;;=I34.1^^172^2266^19
;;^UTILITY(U,$J,358.3,45369,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45369,1,3,0)
;;=3^Nonrheumatic mitral valve prolapse
;;^UTILITY(U,$J,358.3,45369,1,4,0)
;;=4^I34.1
;;^UTILITY(U,$J,358.3,45369,2)
;;=^5007170
;;^UTILITY(U,$J,358.3,45370,0)
;;=I35.0^^172^2266^17
;;^UTILITY(U,$J,358.3,45370,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45370,1,3,0)
;;=3^Nonrheumatic aortic valve stenosis
;;^UTILITY(U,$J,358.3,45370,1,4,0)
;;=4^I35.0
;;^UTILITY(U,$J,358.3,45370,2)
;;=^5007174
;;^UTILITY(U,$J,358.3,45371,0)
;;=I35.2^^172^2266^18
;;^UTILITY(U,$J,358.3,45371,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45371,1,3,0)
;;=3^Nonrheumatic aortic valve stenosis w/ insufficiency
;;^UTILITY(U,$J,358.3,45371,1,4,0)
;;=4^I35.2
;;^UTILITY(U,$J,358.3,45371,2)
;;=^5007176
;;^UTILITY(U,$J,358.3,45372,0)
;;=I42.8^^172^2266^7
;;^UTILITY(U,$J,358.3,45372,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45372,1,3,0)
;;=3^Cardiomyopathies, other
;;^UTILITY(U,$J,358.3,45372,1,4,0)
;;=4^I42.8
;;^UTILITY(U,$J,358.3,45372,2)
;;=^5007199
;;^UTILITY(U,$J,358.3,45373,0)
;;=I48.91^^172^2266^3
;;^UTILITY(U,$J,358.3,45373,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45373,1,3,0)
;;=3^Atrial fibrillation, unspec
;;^UTILITY(U,$J,358.3,45373,1,4,0)
;;=4^I48.91
;;^UTILITY(U,$J,358.3,45373,2)
;;=^5007229
;;^UTILITY(U,$J,358.3,45374,0)
;;=I48.92^^172^2266^4
;;^UTILITY(U,$J,358.3,45374,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45374,1,3,0)
;;=3^Atrial flutter, unspec
;;^UTILITY(U,$J,358.3,45374,1,4,0)
;;=4^I48.92
;;^UTILITY(U,$J,358.3,45374,2)
;;=^5007230
;;^UTILITY(U,$J,358.3,45375,0)
;;=I49.3^^172^2266^23
;;^UTILITY(U,$J,358.3,45375,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45375,1,3,0)
;;=3^Ventricular premature depolarization
;;^UTILITY(U,$J,358.3,45375,1,4,0)
;;=4^I49.3
;;^UTILITY(U,$J,358.3,45375,2)
;;=^5007233
;;^UTILITY(U,$J,358.3,45376,0)
;;=I50.9^^172^2266^6
;;^UTILITY(U,$J,358.3,45376,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45376,1,3,0)
;;=3^CHF
;;^UTILITY(U,$J,358.3,45376,1,4,0)
;;=4^I50.9
;;^UTILITY(U,$J,358.3,45376,2)
;;=^5007251
;;^UTILITY(U,$J,358.3,45377,0)
;;=I69.928^^172^2266^22
;;^UTILITY(U,$J,358.3,45377,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45377,1,3,0)
;;=3^Speech/lang deficits following unsp cerebvasc disease
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2UG 3758 printed Nov 22, 2024@17:46:12 Page 2
IBDEI2UG ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45365,1,3,0)
+2 ;;=3^Myocardial infarctions (STEMI), unspec site
+3 ;;^UTILITY(U,$J,358.3,45365,1,4,0)
+4 ;;=4^I21.3
+5 ;;^UTILITY(U,$J,358.3,45365,2)
+6 ;;=^5007087
+7 ;;^UTILITY(U,$J,358.3,45366,0)
+8 ;;=I25.10^^172^2266^2
+9 ;;^UTILITY(U,$J,358.3,45366,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,45366,1,3,0)
+12 ;;=3^Athscl hrt disease w/o angina pectoris
+13 ;;^UTILITY(U,$J,358.3,45366,1,4,0)
+14 ;;=4^I25.10
+15 ;;^UTILITY(U,$J,358.3,45366,2)
+16 ;;=^5007107
+17 ;;^UTILITY(U,$J,358.3,45367,0)
+18 ;;=I25.2^^172^2266^20
+19 ;;^UTILITY(U,$J,358.3,45367,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,45367,1,3,0)
+22 ;;=3^Old myocardial infarction
+23 ;;^UTILITY(U,$J,358.3,45367,1,4,0)
+24 ;;=4^I25.2
+25 ;;^UTILITY(U,$J,358.3,45367,2)
+26 ;;=^259884
+27 ;;^UTILITY(U,$J,358.3,45368,0)
+28 ;;=I30.0^^172^2266^14
+29 ;;^UTILITY(U,$J,358.3,45368,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,45368,1,3,0)
+32 ;;=3^Idiopathic pericarditis, acute
+33 ;;^UTILITY(U,$J,358.3,45368,1,4,0)
+34 ;;=4^I30.0
+35 ;;^UTILITY(U,$J,358.3,45368,2)
+36 ;;=^5007157
+37 ;;^UTILITY(U,$J,358.3,45369,0)
+38 ;;=I34.1^^172^2266^19
+39 ;;^UTILITY(U,$J,358.3,45369,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,45369,1,3,0)
+42 ;;=3^Nonrheumatic mitral valve prolapse
+43 ;;^UTILITY(U,$J,358.3,45369,1,4,0)
+44 ;;=4^I34.1
+45 ;;^UTILITY(U,$J,358.3,45369,2)
+46 ;;=^5007170
+47 ;;^UTILITY(U,$J,358.3,45370,0)
+48 ;;=I35.0^^172^2266^17
+49 ;;^UTILITY(U,$J,358.3,45370,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,45370,1,3,0)
+52 ;;=3^Nonrheumatic aortic valve stenosis
+53 ;;^UTILITY(U,$J,358.3,45370,1,4,0)
+54 ;;=4^I35.0
+55 ;;^UTILITY(U,$J,358.3,45370,2)
+56 ;;=^5007174
+57 ;;^UTILITY(U,$J,358.3,45371,0)
+58 ;;=I35.2^^172^2266^18
+59 ;;^UTILITY(U,$J,358.3,45371,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,45371,1,3,0)
+62 ;;=3^Nonrheumatic aortic valve stenosis w/ insufficiency
+63 ;;^UTILITY(U,$J,358.3,45371,1,4,0)
+64 ;;=4^I35.2
+65 ;;^UTILITY(U,$J,358.3,45371,2)
+66 ;;=^5007176
+67 ;;^UTILITY(U,$J,358.3,45372,0)
+68 ;;=I42.8^^172^2266^7
+69 ;;^UTILITY(U,$J,358.3,45372,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,45372,1,3,0)
+72 ;;=3^Cardiomyopathies, other
+73 ;;^UTILITY(U,$J,358.3,45372,1,4,0)
+74 ;;=4^I42.8
+75 ;;^UTILITY(U,$J,358.3,45372,2)
+76 ;;=^5007199
+77 ;;^UTILITY(U,$J,358.3,45373,0)
+78 ;;=I48.91^^172^2266^3
+79 ;;^UTILITY(U,$J,358.3,45373,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,45373,1,3,0)
+82 ;;=3^Atrial fibrillation, unspec
+83 ;;^UTILITY(U,$J,358.3,45373,1,4,0)
+84 ;;=4^I48.91
+85 ;;^UTILITY(U,$J,358.3,45373,2)
+86 ;;=^5007229
+87 ;;^UTILITY(U,$J,358.3,45374,0)
+88 ;;=I48.92^^172^2266^4
+89 ;;^UTILITY(U,$J,358.3,45374,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,45374,1,3,0)
+92 ;;=3^Atrial flutter, unspec
+93 ;;^UTILITY(U,$J,358.3,45374,1,4,0)
+94 ;;=4^I48.92
+95 ;;^UTILITY(U,$J,358.3,45374,2)
+96 ;;=^5007230
+97 ;;^UTILITY(U,$J,358.3,45375,0)
+98 ;;=I49.3^^172^2266^23
+99 ;;^UTILITY(U,$J,358.3,45375,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,45375,1,3,0)
+102 ;;=3^Ventricular premature depolarization
+103 ;;^UTILITY(U,$J,358.3,45375,1,4,0)
+104 ;;=4^I49.3
+105 ;;^UTILITY(U,$J,358.3,45375,2)
+106 ;;=^5007233
+107 ;;^UTILITY(U,$J,358.3,45376,0)
+108 ;;=I50.9^^172^2266^6
+109 ;;^UTILITY(U,$J,358.3,45376,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,45376,1,3,0)
+112 ;;=3^CHF
+113 ;;^UTILITY(U,$J,358.3,45376,1,4,0)
+114 ;;=4^I50.9
+115 ;;^UTILITY(U,$J,358.3,45376,2)
+116 ;;=^5007251
+117 ;;^UTILITY(U,$J,358.3,45377,0)
+118 ;;=I69.928^^172^2266^22
+119 ;;^UTILITY(U,$J,358.3,45377,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,45377,1,3,0)
+122 ;;=3^Speech/lang deficits following unsp cerebvasc disease
